Novo Nordisk A/S shares are bouncing back from their worst ever year , with bulls hoping that a pill version of its blockbuster obesity shot will help finally turn things around for the Danish drugmaker. The stock has gained 14% so far in January, set for its best month since August. Novo started selling its Wegovy pill a few weeks ago, beating rival Eli Lilly & Co. to market and boosting sentimen...
Novo Nordisk A/S shares are bouncing back from their worst ever year , with bulls hoping that a pill version of its blockbuster obesity shot will help finally turn things around for the Danish drugmaker. The stock has gained 14% so far in January, set for its best month since August. Novo started selling its Wegovy pill a few weeks ago, beating rival Eli Lilly & Co. to market and boosting sentiment after a string of bad news pummeled the shares last year. “2026 will be a transition year,” said Robert Hannaford , deputy portfolio manager of the Evenlode Global Income fund, adding that the pill launch seems to be going well. “Longer term, the growth opportunity for them is enormous.” Analysts at Goldman Sachs Group Inc. agree. They recently hiked their price target on Novo shares, saying the Wegovy pill should drive sentiment in the near term. A turnaround can’t come soon enough. After a year that included disappointing clinical trial results and multiple profit warnings, Novo shares had been left trading as if the craze surrounding obesity drugs never happened . The company also named a new chief executive officer, Mike Doustdar , and overhauled its board last year. Doustdar has been “tasked with righting the ship and has been adamant that major strategic changes are unlikely,” according to TD Cowen analyst Michael Nedelcovych , who said he is “cautiously optimistic” about Novo regaining steam. The company’s first major challenge is to capitalize on its first-mover advantage in oral GLP-1s. Competition will be fierce, with pills seen as key to expanding the market for obesity drugs as a more convenient option for patients than injections. A US regulatory decision on Eli Lilly’s pill — called orforglipron — is expected next quarter. The first few weeks of sales for the Wegovy pill have “undoubtedly been strong,” according to Jefferies analyst Michael Leuchten . Even so, “we are yet to see expansion of Novo’s overall GLP-1 volumes following launch.” A more immediate ca...
Spending on AI infrastructure is expected to be measured in the trillions of dollars. The S&P 500 finished 2025 with a total return of 18% -- its third consecutive year with a double-digit gain. The trend of ongoing technological dominance continues, as the market has more recently been lifted by the artificial intelligence (AI) boom. There are certainly fears these days that we are in an AI-infla...
Spending on AI infrastructure is expected to be measured in the trillions of dollars. The S&P 500 finished 2025 with a total return of 18% -- its third consecutive year with a double-digit gain. The trend of ongoing technological dominance continues, as the market has more recently been lifted by the artificial intelligence (AI) boom. There are certainly fears these days that we are in an AI-inflated bubble in 2026. Despite this backdrop, is it still a smart idea for investors to buy a leading S&P 500 exchange-traded fund (ETF)? Key factors supporting the AI bubble argument The most obvious sign that we might be in an AI bubble is the massive amount of capital being invested to build out the technical infrastructure for related projects. "We see $3 trillion to $4 trillion in AI infrastructure spend by the end of the decade," Nvidia CFO Colette Kress said last August. That's a jaw-dropping forecast sum that isn't supported yet by returns on invested capital. For instance, research from Menlo Ventures estimates that only 3% of users pay for AI services. And the dominant tech companies that are leveraging AI capabilities so far might be seeing only incremental improvements, not game-changing leaps. Valuations can't be ignored, either. Palantir Technologies trades at a nose-bleed price-to-sales ratio of 110. This multiple wouldn't happen if there weren't such huge hype surrounding AI. To be clear, I have zero clue whether we're in a bubble or not. These trends certainly can make investors uneasy. However, the bullish fever can continue longer than anyone can predict. Keep things simple, and focus on the long term Even accounting for the AI bubble fears, I believe investors should still be thinking about putting money to work. The Vanguard S&P 500 ETF (VOO 0.21%) is an excellent choice, particularly since it carries an expense ratio of just 0.03%. Expand NYSEMKT : VOO Vanguard S&P 500 ETF Today's Change ( -0.21 %) $ -1.33 Current Price $ 638.27 Key Data Points Day's Rang...
In just two days, three Chinese property companies have tapped the international bond market in the busiest week in almost four years, taking advantage of improving sentiment for the sector. State-backed Yuexiu Property Co Ltd. and China Overseas Grand Oceans Group Ltd. are marketing offshore yuan notes on Friday. The timing is unusual, underscoring the revival of interest. Friday is generally a n...
In just two days, three Chinese property companies have tapped the international bond market in the busiest week in almost four years, taking advantage of improving sentiment for the sector. State-backed Yuexiu Property Co Ltd. and China Overseas Grand Oceans Group Ltd. are marketing offshore yuan notes on Friday. The timing is unusual, underscoring the revival of interest. Friday is generally a no-go zone as issuance can involve late nights, which most investors prefer to avoid heading into the weekend. The deals add to a $360 million security from Dalian Wanda Commercial Management Group Co. on Thursday, its first such sale in three years. The last time that Chinese builders priced more than three offshore notes in a week was in mid 2022, according to data compiled by Bloomberg. That was before an unprecedented property crisis worsened further and effectively locked the majority of such firms out of global credit markets. Several developments this week buoyed the broader mood for the sector. Two industry heavyweights, Shenzhen-based China Vanke Co. and Hong Kong-listed developer New World Development Co. , made progress in efforts to further distance themselves from crises that previously left them on the verge of default. News also emerged that developers stopped filing regular reports on their so‑called “three red lines” as early as 2023, after officials dialed back the stringent leverage metrics that exacerbated the real estate meltdown. New World Shares, Bonds Jump as Blackstone in Talks for Stake Hong Kong’s Housing Market Rebounds With Renewed City Buzz China Builders Ceased Reporting ‘Three Red Lines’ Years Ago “Recent positive tailwinds should be good for the new bond pricing,” said Ting Meng , senior Asia credit strategist at Australia & New Zealand Banking Group Ltd. There are, of course, still plenty of challenges for Chinese developers. The years-long real estate crisis has led to record defaults and restructurings. And property sales have still genera...
Elon Musk has once again fueled merger speculation after reports said SpaceX is exploring a potential tie-up involving xAI and Tesla Inc. (NASDAQ:TSLA) as it prepares for what could be one of the largest IPOs in history. SpaceX, xAI And Tesla: Merger Talk Gains Momentum SpaceX has reportedly been holding internal discussions around a possible merger involving Tesla and xAI. The space exploration c...
Elon Musk has once again fueled merger speculation after reports said SpaceX is exploring a potential tie-up involving xAI and Tesla Inc. (NASDAQ:TSLA) as it prepares for what could be one of the largest IPOs in history. SpaceX, xAI And Tesla: Merger Talk Gains Momentum SpaceX has reportedly been holding internal discussions around a possible merger involving Tesla and xAI. The space exploration company is reportedly targeting an IPO as early as June at a valuation of around $1.5 trillion, a move that would instantly make it one of the most valuable publicly traded firms in the world. Gene Munster Breaks Down The Odds On Thursday, Deepwater Asset Management's managing partner Gene Munster weighed in on X, calling the situation a classic example of "Elon thinking big." Munster outlined his view of how the scenario could play out over the next three years, assigning a 45% chance that Tesla acquires xAI, a 35% chance SpaceX buys xAI and a 20% probability that xAI remains independent. "My take: Investors would likely approve the deal (either SpaceX or Tesla buying xAI) because it’s Elon thinking big, future versions of Colossus belong in space," Munster wrote. Both SpaceX and Tesla have already invested $2 billion each into xAI. Why AI Is Central To Musk's Strategy In a separate post, Munster said Musk's companies "will always play nice with each other," outlining how each could benefit from xAI. SpaceX, he said, wants xAI to power datacenters "in the sky," while Tesla would leverage Grok, xAI's chatbot, for Full Self-Driving software and the Optimus humanoid robot program. "If SpaceX buys xAI, Tesla will still get access to Grok," Munster added. Investor Chamath Palihapitiya also took to X and said that a merger between SpaceX and Tesla would instantly create a modern-day Berkshire Hathaway. “If this were to happen, it would also bring us one step closer to having one equity instrument for all things Elon which many would want to buy,” he said. IPO Timing And Market Be...
(RTTNews) - TOKYO GAS (TOG.F, 9531.T) reported that its nine-month profit attributable to owners of parent was 166.3 billion yen compared to 33.53 billion yen, last year. Basic earnings per share was 474.54 yen compared to 85.96 yen. For the nine months ended December 31, 2025, net sales were 2.0 trillion yen, up 10.6%. For the fiscal year ending March 31, 2026, the company expects: profit attribu...
(RTTNews) - TOKYO GAS (TOG.F, 9531.T) reported that its nine-month profit attributable to owners of parent was 166.3 billion yen compared to 33.53 billion yen, last year. Basic earnings per share was 474.54 yen compared to 85.96 yen. For the nine months ended December 31, 2025, net sales were 2.0 trillion yen, up 10.6%. For the fiscal year ending March 31, 2026, the company expects: profit attributable to owners of parent of 194.0 billion yen, basic earnings per share of 560.15 yen, and net sales of 2.89 trillion yen. TOKYO GAS is currently trading at 6,961 yen, up 3.6%. For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Prudential Financial Inc. ’s India asset manager has received offers from at least two local bidders, according to people with knowledge of the matter. State Street Investment Management-backed Groww Asset Management Ltd. and Edelweiss Asset Management have placed bids for PGIM India Asset Management Pvt Ltd., the people said, asking to remain anonymous as the information is private. PGIM Inc. is ...
Prudential Financial Inc. ’s India asset manager has received offers from at least two local bidders, according to people with knowledge of the matter. State Street Investment Management-backed Groww Asset Management Ltd. and Edelweiss Asset Management have placed bids for PGIM India Asset Management Pvt Ltd., the people said, asking to remain anonymous as the information is private. PGIM Inc. is looking to sell its loss-making India asset management unit after seeing little meaningful expansion since it acquired the business from Deutsche Bank AG a decade ago. Negotiations are ongoing and a deal hasn’t been finalized, the people said. PGIM declined to comment while, Groww AMC and Edelweiss AMC did not respond to a request for comment. Global asset managers are investing in India to take advantage of its ongoing equity boom. State Street Investment Management picked up a minority stake in Groww AMC earlier this month. Similarly, Westbridge Capital bought a stake in Edelweiss AMC in August while Johannesburg-based Sanlam Emerging Markets (Mauritius) Ltd. acquired a stake in Shriram AMC in May. PGIM has assets across fixed income, equity, alternatives and real estate. PGIM’s after-tax losses in India rose to more than 235 million rupees ($2.6 million) in the year ended March 2025, according to its annual report.
Robert Way CSPC Pharmaceutical Group said on Friday it has signed an agreement with UK drugmaker AstraZeneca ( AZN ) to jointly develop innovative long-acting peptide therapies targeting obesity and related weight-management conditions. For access to eight programs and related platforms, AstraZeneca ( AZN ) will pay the group an upfront $1.2 billion, with the potential for up to $3.5 billion in re...
Robert Way CSPC Pharmaceutical Group said on Friday it has signed an agreement with UK drugmaker AstraZeneca ( AZN ) to jointly develop innovative long-acting peptide therapies targeting obesity and related weight-management conditions. For access to eight programs and related platforms, AstraZeneca ( AZN ) will pay the group an upfront $1.2 billion, with the potential for up to $3.5 billion in research and development milestones, up to $13.8 billion in sales-based milestone payments, and royalties of up to double-digit percentages tied to annual net sales of the licensed products. More on AstraZeneca 44th Annual J.P. Morgan Healthcare Conference AstraZeneca PLC (AZN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript AstraZeneca: Oncology Dominance Justifies New All-Time Highs AstraZeneca to invest $15B in China through 2030 AstraZeneca signs research agreement with University of Virginia
Technical indicators signal an intensifying downward bias that is challenging established bullish patterns in the short term. For the full year 2025, Tesla’s total revenue fell by 3%, while earnings per share experienced a significant 31% decline over the same period. Despite exceeding quarterly revenue and EPS forecasts, Tesla shares closed 3.45% lower as investors reacted to stagnant performance...
Technical indicators signal an intensifying downward bias that is challenging established bullish patterns in the short term. For the full year 2025, Tesla’s total revenue fell by 3%, while earnings per share experienced a significant 31% decline over the same period. Despite exceeding quarterly revenue and EPS forecasts, Tesla shares closed 3.45% lower as investors reacted to stagnant performance in the core automotive division. Tesla Inc. surpasses forecasts, yet shares retreat amid revenue and income contraction Tesla reported quarterly revenue of $24.9 billion, marginally ahead of the $24.7 billion consensus, with an EPS of $0.50 exceeding the $0.45 estimate. Consequently, the shares closed down 3.45% at $416.56. This decline is largely attributed to a 6.3% year-on-year (YoY) contraction in the "Automotive" segment, the firm’s primary revenue driver. In contrast, the "Energy Generation and Storage" segment demonstrated robust growth, with a 26% annual increase in 2025. Despite this diversification, the 31% YoY drop in total EPS remains a point of concern for market participants. Financial analysis of Tesla Inc. From a fundamental perspective, Tesla has maintained a long-term upward trajectory in total revenue, yet growth has stagnated over the last eight quarters. The YoY revenue growth rate has decelerated since 2022, resulting in a negative performance during the most recent fiscal year. Consequently, net income has been adversely affected, exhibiting a downward trend since 2024. Figure 1. Total revenue, net income, and respective growth rates of Tesla Inc. (2019–2025). Source: Own analysis using data from the Nasdaq Exchange. As illustrated in Figure 2, Tesla’s net margin has compressed in tandem with the decline in net income. After reaching a peak in Q4 2023, the profit margin narrowed to approximately 4% by the end of 2025. Figure 2. Net margin trend and profitability analysis of Tesla Inc. (2019–2025). Source: Own analysis using data from the Nasdaq Excha...
Hong Kong-based CK Hutchison Holdings, controlled by billionaire Li Ka-shing, risks losing its rights to operate major ports at both ends of the Panama Canal after the country’s Supreme Court ruled its subsidiary’s contract unconstitutional. The decision was announced in a statement posted on the official social media account of the Panama Judiciary on Thursday local time. In the statement, the Pa...
Hong Kong-based CK Hutchison Holdings, controlled by billionaire Li Ka-shing, risks losing its rights to operate major ports at both ends of the Panama Canal after the country’s Supreme Court ruled its subsidiary’s contract unconstitutional. The decision was announced in a statement posted on the official social media account of the Panama Judiciary on Thursday local time. In the statement, the Palace of Justice Gil Ponce said the concession contract for the development, construction, operation, administration and management of the Balboa and Cristobal ports between the state and the Panama Ports Company (PPC), a CK Hutchison subsidiary, was unconstitutional. Advertisement The statement added that the decision was reached “following extensive deliberation and discussion”. CK Hutchison holds a 90 per cent stake in PPC, which had a 25-year concession to operate the Balboa and Cristobal ports that was renewed in 2021. Advertisement The South China Morning Post has reached out to CK Hutchison for comment.